Tilray Brands, Inc.

TLRY Nasdaq CIK: 0001731348

Company Information

Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Large accelerated filer
Business Address 655 MADISON AVENUE, NEW YORK, NY, 10065
Mailing Address 655 MADISON AVENUE, NEW YORK, NY, 10065
Phone 519.322.8800
Fiscal Year End 0531
EIN 824310622

Financial Overview

FY2025

-$244.98M
Net Income
$228.34M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 1, 2026 View on SEC
10-Q Quarterly financial report April 1, 2026 View on SEC
8-K Current report of material events March 2, 2026 View on SEC
10-Q Quarterly financial report January 8, 2026 View on SEC
4 Insider stock transaction report January 8, 2026 View on SEC
8-K Current report of material events January 8, 2026 View on SEC
8-K Current report of material events November 26, 2025 View on SEC
8-K Current report of material events November 19, 2025 View on SEC
8-K Current report of material events November 17, 2025 View on SEC
10-Q Quarterly financial report October 9, 2025 View on SEC

Material Events

8-K Acquisition April 1, 2026
High Impact
  • Record quarterly revenue of $207 million, marking an 11% year-over-year increase.
  • Strategic $415 million all-stock acquisition of BrewDog to expand global beverage footprint.
View Analysis
8-K Acquisition March 2, 2026
High Impact
  • Tilray Brands acquired key operational assets from BrewDog Group, significantly expanding its global beverage alcohol business.
  • The acquisition, valued at approximately £33 million ($44.1 million USD), was financed using existing cash reserves without incurring new debt or issuing equity.
View Analysis

Related Companies

Companies in the same industry (SIC: 2833)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.